In Vivo Epithelial Metabolic Imaging Using a Topical Fluorescent Glucose Analog

Paula Villarreal, Rahul Pal, Gracie Vargas

    Research output: Chapter in Book/Report/Conference proceedingChapter

    2 Scopus citations

    Abstract

    The demanding metabolic needs of cancer cells are met by aerobic glycolysis. While whole-body PET imaging methods exist for evaluating this metabolic response, these are not ideal for local, more detailed regions such as mucosal surfaces. Fluorescence imaging of glucose analogs with similarities to radiolabeled deoxyglucose used in PET, namely, fluorescent 2-deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-d-glucose (2-NBDG), offers such an alternative, particularly as this glucose analog may be delivered by local topical delivery. In this chapter, methods for in vivo epithelial imaging in a preclinical hamster model for oral cancer and oral epithelial dysplasia are described. Outlined are methods for preparation and in vivo delivery of 2-NBDG by topical application to the oral mucosa followed by fluorescence imaging to compare fluorescence responses between neoplasia and control mucosa or to monitor changes in fluorescence signal with time in both groups.

    Original languageEnglish (US)
    Title of host publicationMethods in Molecular Biology
    PublisherHumana Press Inc.
    Pages21-31
    Number of pages11
    DOIs
    StatePublished - 2020

    Publication series

    NameMethods in Molecular Biology
    Volume2126
    ISSN (Print)1064-3745
    ISSN (Electronic)1940-6029

    Keywords

    • Epithelial cancer
    • Epithelial dysplasia
    • Fluorescence
    • Glycolysis
    • Intravital
    • Metabolism
    • Optical Imaging
    • Oral squamous cell carcinoma

    ASJC Scopus subject areas

    • Molecular Biology
    • Genetics

    Fingerprint

    Dive into the research topics of 'In Vivo Epithelial Metabolic Imaging Using a Topical Fluorescent Glucose Analog'. Together they form a unique fingerprint.

    Cite this